Mestag Therapeutics
Mestag Therapeutics is an immunology company focused on developing treatments for cancer and inflammatory diseases. They are advancing a pipeline of therapies based on their understanding of fibroblast biology.
- MST-0300 bispecific antibody
- First-in-class cancer therapies
- M402 stromal checkpoint agonist
- Innovative treatments for inflammatory diseases
- Reversing Activated Fibroblast Technology (RAFT) platform
Locations
Digital Popularity
Social Media
Company Details
Mestag Therapeutics is operated by Mestag Therapeutics Ltd and is a Active company incorporated on 17 February 2020 with the registered office located in Saffron Walden, Essex. Mestag Therapeutics Ltd was registered 5 years ago.
Status
Active
Size
Micro
Directors
10
Age
5 years old
Employees
42
Turnover
Unreported
Total Assets
£29.32M
Cash in Bank
£23.58M
Total Liabilities
-£60.98M
Teams
44
22
14
4
2
2
10
Chief Executive Officer • Joined Jan 2020
Co-founder • Joined May 2020
Principal Scientist • Joined Jan 2023
Principal Scientist • Joined Jan 2025
Principal Scientist • Joined Jul 2021
Chairman Of The Board
Principal Scientist I • Joined Jan 2025
Principal Scientist II • Joined Apr 2022
Principal Scientist II • Joined Jan 2025
Associate Director, Head Of People • Joined Jul 2024
Principal Scientist • Joined Jan 2023
Principal Scientist • Joined Jan 2025
Principal Scientist • Joined Jul 2021
Principal Scientist I • Joined Jan 2025
Principal Scientist II • Joined Apr 2022
Principal Scientist II • Joined Jan 2025
Laboratory Support Technician • Joined Oct 2023
Senior Research Associate • Joined Oct 2024
Senior Scientist II • Joined Dec 2021
Scientist II • Joined May 2024
Chief Executive Officer • Joined Jan 2020
Co-founder • Joined May 2020
Principal Scientist • Joined Jan 2023
Principal Scientist • Joined Jan 2025
Principal Scientist • Joined Jul 2021
Chairman Of The Board
Principal Scientist I • Joined Jan 2025
Principal Scientist II • Joined Apr 2022
Principal Scientist II • Joined Jan 2025
Program Lead • Joined Sep 2021
Executive Assistant • Joined Aug 2024
Office Manager • Joined Jan 2023
People Operations Assistant • Joined Nov 2023
General Counsel • Joined Oct 2024
Program Lead • Joined Sep 2021
Senior Director Translational Science • Joined Feb 2024
Director Of Finance • Joined May 2023
Financial Accountant • Joined Jul 2023
Associate Director, Head Of People • Joined Jul 2024
VP Head Of Corporate Development • Joined May 2021
Talent Lead And Sole 360 Recruiter. (Interim Project) • Joined Feb 2023
Talent Acquisition Manager (Via Northreach Talent) • Joined Nov 2022
Senior Associate Corporate Development • Joined Feb 2025
Corporate Development And Strategy MBA Associate • Joined Oct 2024
VP Target Discovery • Joined Jun 2021
Scientist I - Immunology • Joined Sep 2024
Senior Scientist I - In Vivo • Joined Aug 2023
Scientist II - Antibody Discovery And Engineering • Joined Sep 2023
View 44 members